Duke Royalty Ltd said Wednesday it still expects its cashflow and loan portfolio for its financial year to be in line with expectations, despite the market turbulence affecting all public companies.
Duke Royalty Ltd on Monday said it has invested an additional GBP1 million into existing royalty partner Lynx Equity UK Ltd. The investment will be used to fund Lynx’s acquisition of Danish door manufacturer Arkas AS, agreed in February.
“We are a serious investor in Ireland; we see it as a very attractive opportunity and place for us to do business. We’ve now got a very strong network of both portfolio companies and relationships in the corporate finance community.”
Duke Royalty announced a follow-on investment of around £7.7m into its existing royalty partner, Bakhchysarai Ireland (BIL), on Thursday. It said the new capital would support BIL’s second acquisition, PharmEng, trading as PE Global, which it described as “one of the leading” healthcare and life sciences recruiters in Ireland, with a growing presence in the UK.
Alternative capital provider Duke Royalty announced a follow-on investment of around £7.7m into its existing royalty partner, Bakhchysarai Ireland (BIL), on Thursday.
Duke Royalty Ltd said Monday it completed three follow-on investments in December.
There is also quarterly-dividend paying Duke Royalty which lends money to private companies on a long-term basis, typically between 25 and 40 years, in exchange for part of their revenue.
Duke Royalty is unique in the UK, although its royalty model is well known in North America. Duke’s royalty income-based model provides cash generation and an attractive yield. Duke has the finance to grow the business and companies are becoming more aware of the attractions of royalty-based finance rather than bringing in private equity backers or floating on the stockmarket.
